Shanghai ShineYo Medical Device Co., Ltd, a company specializing in electrophysiology and peripheral intervention, has reportedly secured RMB 100 million (USD 14.93 million) in a Series A financing round. The funding was led by Apricot Capital and Industrial Securities Capital, with participation from Dalton Venture, Bangming Capital, and HiMed Angle Fund. The proceeds will be utilized for expanding the product pipeline, advancing clinical trials, and recruiting additional staff.
Company Overview and Use of Funds
Founded in 2020, ShineYo Medical Device provides solutions targeting conditions such as atrial fibrillation and varicose veins. The company has initiated a clinical study for its internally developed multi-channel pulsed electric field ablation instrument, highlighting its commitment to innovation and expanding its therapeutic offerings.-Fineline Info & Tech
